Manifold MarketsSans KYCDonnées de résolution vérifiéesBien calibréPrévision communautaire actuelleNon 85.7%
Prévisionnistes
18
Type de question
binary
Méthodologie
Play-money forecasting platform
Type de source
Prévision
Données du marché
Mis à jour il y a 26 minutes
3 août 23, 18:56 UTC2 janv. 28, 07:59 UTC
Tendances
Règles
Recently the small molecule drug AOH1996 has recieved some attention on social media for its potential to treat a variety of cancers with basically no side effects in animal models.
- Here is a good overview: https://www.science.org/content/blog-post/new-mode-cancer-treatment
- The question here is whether this drug will succeed in Phase II trials.
- Unlike the ongoing Phase I trials, which are designed to show safety, Phase II trails must show efficacy.
- Success can unambiguously be defined as either FDA approval (under an accelerated approval process, which this drug may get) or advancing to Phase III trails.
- (Note that in Phase III trials a drug is evaluated for comparative efficacy against other treatment options).
